Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists
Author:
Affiliation:
1. St. John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; London U.K
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15645/fullpdf
Reference12 articles.
1. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial;Chaudhari;Lancet,2001
2. Update on psoriasis pathogenesis and treatment of psoriasis and targeted immunotherapy;Mahil;Semin Immunopathol,2016
3. National Institute for Health and Care Excellence Psoriasis (plaque, chronic, severe, children, young people) - adalimumab, etanercept and ustekinumab [ID854] https://www.nice.org.uk/guidance/indevelopment/gid-ta10021
4. Secukinumab shows significant efficacy in palmoplantar psoriasis: results from GESTURE, a randomized controlled trial;Gottlieb;J Am Acad Dermatol,2017
5. Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR);Warren;J Invest Dermatol,2015
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study;Journal of Clinical Medicine;2023-11-21
2. Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis;Experimental Dermatology;2023-04-26
3. Novel RNA polymerase I inhibitor CX ‐5461 suppresses imiquimod‐induced experimental psoriasis;Experimental Dermatology;2022-10-07
4. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study;Journal of the American Academy of Dermatology;2020-06
5. Rates of psoriasis in patients with palmoplantar pustulosis;British Journal of Dermatology;2019-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3